Abstract

Chlamydia trachomatis infections are the leading cause of sexually transmitted infections of bacterial origin. Lower genital tract infections are often asymptomatic, and therefore left untreated, leading to ascending infections that have long-term consequences on female reproductive health. Human pathology can be recapitulated in mice with the mouse adapted strain C. muridarum. Eight years into the post-genetic era, significant advances to expand the Chlamydia genetic toolbox have been made to facilitate the study of this important human pathogen. However, the need for additional tools remains, especially for C. muridarum. Here, we describe a new set of spectinomycin resistant E. coli-Chlamydia shuttle vectors, for C. trachomatis and C. muridarum. These versatile vectors allow for expression and localization studies of Chlamydia effectors, such as Inc proteins, and will be instrumental for mutant complementation studies. In addition, we have exploited the differential expression of specific Chlamydia genes during the developmental cycle to engineer an omcA::gfp fluorescent transcriptional reporter. This novel tool allows for monitoring RB to EB conversion at the bacterial level. Spatiotemporal tracking of GFP expression within individual inclusions revealed that RB to EB conversion initiates in bacteria located at the edge of the inclusion and correlates with the time post initiation of bacterial replication and inclusion size. Comparison between primary and secondary inclusions potentially suggests that the environment in which the inclusions develop influences the timing of conversion. Altogether, the Chlamydia genetic tools described here will benefit the field, as we continue to investigate the molecular mechanisms underlying Chlamydia-host interaction and pathogenesis.

Highlights

  • Chlamydia spp. are Gram-negative obligate intracellular bacterial pathogens that infect a wide range of hosts and are responsible for various diseases

  • A new set of spectinomycin resistant cloning vectors for Chlamydia trachomatis Following the development of a transformation system for Chlamydia [14], we described a series of p2TK2Amp-SW2 E. coli-C. trachomatis shuttle cloning vectors [15, 17]

  • The incDEFG promoter, which is expressed throughout the developmental cycle [40], was chosen to drive the expression of the aminoglycoside adenyltransferase gene (aadA) gene to ensure the constitutive expression of the antibiotic resistance

Read more

Summary

Introduction

Chlamydia spp. are Gram-negative obligate intracellular bacterial pathogens that infect a wide range of hosts and are responsible for various diseases. Chlamydia trachomatis is the leading cause of sexually transmitted infections of bacterial origin and the most common cause of non-congenital blindness due to trachoma [1]. In the lumen of the inclusion, Chlamydia undergoes a bi-phasic developmental cycle that is shared by all species and lasts 2–3 days. This cycle is characterized by alternation between two very distinct morphological and functional forms of the bacterium: a small, electron-dense, infectious elementary body (EB) and a larger, more electron-lucent, replicative reticulate body (RB) [5, 6]. RBs replicate to high number and, beginning mid-cycle, start their asynchronous conversion back to infectious EBs [7]. At the end of the cycle, inclusions contain a large number of EBs that are released by successive lysis of the inclusion and host plasma membranes or by extrusion [8]

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call